Report - JOURNÉE DE PRINTEMPS DU GRSSGO · A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal

Please pass captcha verification before submit form